Pediatric lupus versus adult lupus role of the laboratory

Clinical and Applied Immunology Reviews

Volumn 4, Issue 5, 2004, Pages 333-350

  Klein Gitelman, Marisa ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Differences between children and adults with lupus; Immunologic laboratory evaluation; Lupis

Indexed keywords

ABETIMUS; ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AUTOANTIGEN; CORTICOSTEROID; CYCLOSPORIN; DNA ANTIBODY; FC RECEPTOR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HYDROXYCHLOROQUINE; INFLUENZA VACCINE; INTERLEUKIN 10 ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS VACCINE; PRASTERONE; RIBONUCLEOPROTEIN; TETANUS TOXOID; WARFARIN;

ADULT; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC DIFFERENCE; FEMALE; GENETIC DIFFERENCE; GENETIC VARIABILITY; GROUPS BY AGE; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOFLUORESCENCE; INFECTION RISK; LABORATORY DIAGNOSIS; MALE; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SEX RATIO; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 3242814616     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2004.04.001     Document Type: Review

References (93)

1. Liu Z.H. Cheng Z.H. Gong R.J. Liu H. Liu D. Li L.S. Sex differences in estrogen receptor gene polymorphism and its association with lupus nephritis in Chinese Nephron 90 2002 174-180
2. Bogdanovic R. Nikolic V. Pasic S. Dimitrijenc J. Liplovska-Markovic J. Eric Marinkovic J. et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center Pediatr Nephrol 19 2002 36-44
3. Emre S. Bilge I. Sirin A. Kilicaslan I. Nayir A. Oktem F. et al. Lupus nephritis in children: prognostic significance of clinicopathological findings Nephron 87 2001 118-126
4. Marini R. Costallat L.T. Young age at onset, renal involvement and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus Rev Rhum 66 1999 303-309
5. Lo J.T. Tsai M.J. Wang L.H. Sex differences in pediatric systemic lupus erythematosus: a retrospective analysis of 135 cases J Microbiol Immunol Infect 32 1999 173-178
6. Vilarinho S.T. Costallat L. Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus J Rheumatol 25 1998 1097-1103
7. Rood M.J. Van Deer Velde E.A. Ten Cate R. Breedveld V.C. Huizinga T.W.J. Female sex hormones at the onset of systemic lupus erythematosus affect survival Br J Rheumatol 37 1998 1008-1010
8. van Vollenhoven R.E. Engleman E.D. McGuire J.L. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial Arthritis Rheum 38 1995 1826-1831
9. van Vollenhoven R.F. Morabito L.M. Engleman E.G. McGuire J.L. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months J Rheumatol 25 1998 285-289
10. Petri M.A. Lahita R.G. van Vollenhoven R.F. Merrill J.R. Schiff M. Ginzler E.M. et al. Effects of prasterone on corticosteroid requirements if women with systemic lupus erythematosus: a double blind, randomized placebo-controlled trial Arthritis Rheum 46 2002 1820-1829
11. Chang D.M. Lan J.L. Lin H.Y. Luo S.F. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial Arthritis Rheum 46 2002 2924-2927
12. Prystowsky S.D. Herndon J.H. Gilliam J.N. Chronic cutaneous lupus erythematosus (DLE) Medicine 55 1975 183-191
13. Tan E.M. Cohen A.S. Fries J.F. Masi A.T. McShane J.D. Rothfield N.F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE) Arthritis Rheum 25 1982 1271-1277
14. Gonzalez C.M. Lopez-Longo F.J. Monteagudo I. Grau R. Rodriguez-Mahou M. St-Cyr C. et al. Antiribonuclearprotein antibodies in children with human immunodeficiency virus infection: comparative study with childhood onset systemic lupus erythematosus Pediatr AIDS HIV Infect 7 6 1996 401-408
15. Hochberg M.N. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1997 1725
16. Sharp G.C. Irvin W.S. Tan E.M. Gould R.G. Holman H.R. Mixed Connective Tissue Disease- an apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen (ENA) Am J Med 52 1972 148-159
17. Cassidy J.T. Burt A. Petty R. Sullivan D. Selective IgA deficiency in connective tissue diseases N Engl J Med 280 1969 275
18. Rankin E.C. Isenberg D.A. IgA deficiency and SLE: prevalence in a clinic population and a review of the literature Lupus 6 1997 390-394
19. Swaak A.J.G. van den Brink H.G. Case report: common variable immunodeficiency in a patient with systemic lupus erythematosus Lupus 5 1996 242-246
20. Glidden R.S. Mantzouranis E. Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients Clin Immunol Immunopathol 29 1983 196-210
21. King K.K. Kornreich H.K. Bernstein B.H. Singsen B.H. Hanson V. The clinical spectrum of systemic lupus erythematosus in childhood Arthritis Rheum 20 1977 287-294
22. Meislin A.G. Rothfield N. Systemic lupus erythematosus in childhood Pediatrics 42 1968 37-49
23. Janwityanujit S. Totemchokchyakarn K. Verasertniyom O. Vanichapuntu M. Vatanasuk M. Age-related differences on clinical and immunological manifestations of SLE Asian Pacific J Allergy Immunol 13 1995 145-149
24. Carreno K. Lopez-Longo F.J. Monteagudo I. Rodriguez-Mahou M. Bascones M. Gonzalez C.M. et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus Lupus 8 1999 287-292
25. Rood M.J. ten Cate R. van Suijlekom-Smit L.W. denOuden E.J. Ouwerkerk F.E. Breedveld F.C. et al. Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients Scand J Rheumatol 28 1999 222-226
26. Font J. Cervera R. Espinosa G. Pallares L. Ramos-Casals M. Jimenez S. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults Ann Rheum Dis 57 1998 456-459
27. Ginzler E.M. Diamond H.S. Weiner M. Schlesinger M. Fries J.F. Washer C. et al. A multicenter study of outcome of systemic lupus erythematosus: I. Entry variables as predictors of progress Arthritis Rheum 25 1982 601-611
28. Abeles M. Urman J.D. Weinstein A. Lowenstein M. Rothfield N.F. Systemic lupus erythematosus in the younger patient: survival studies J Rheumatol 7 1980 515-522
29. Lehman T.J.A. McCurdy D. Spencer C. Silverman E. Harley J.B. Prognostic value of antibodies to Ro/SSA, SSB/La and RNP in children with systemic lupus erythematosus Arthritis Rheum 33 1990 S154
30. Wallace D.J. Podell T. Weiner J. Klinenberg J.R. Forouzesh S. Dubois E.L. Systemic lupus erythematosus- survival patterns. Experience with 609 patients JAMA 245 1981 934-938
31. Garin E. Shulman S.T. Donnelly W.H. Richard G.A. Systemic lupus erythematosus glomerulonephritis in children Pediatrics 10 1981 351-367
32. Yancey C.L. Doughty R.A. Athreya B.H. Central nervous system involvement in childhood systemic lupus erythematosus Arthritis Rheum 24 1989 1389-1395
33. Tucker L.R. Menon S. Schaller J.G. Isenberg D.A. Adult and childhood onset systemic lupus erythematosus: a comparison of onset, clinical features, serology and outcome Br J Rheumatol 34 1995 866-872
34. Ward M.M. Dawson D.V. Kredich D.W. Pisetsky D.S. Expression of IgM and IgG autoantibodies in pediatric and adult systemic lupus erythematosus Clin Immunol Immunopathol 55 1990 273-284
35. Reichlin M. Faulkner Broyles T. Hubscher O. James J. Lehman T.A. Palermo R. et al. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease Arthritis Rheum 42 1999 69-75
36. Shergy W.J. Kredich D.W. Pisetsky: the relationship of anticardiolipin antibodies to disease manifestations in pediatrics systemic lupus erythematosus J Rheumatol 15 1988 1389-1394
37. Seaman D.E. Londino A.V.Jr. Kwoh C.K. Megsger T.A. Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosus Pediatrics 96 1995 1040-1045
38. Gattorno M. Buoncompagni A. Molinari A.C. Barbano G.C. Morreale G. Stalla F. et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and hig-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome Br J Rheumatol 34 1995 873-881
39. Berube C. Mitchell L. Silverman E. David M. Saint-Cyr C. Laxer R. et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross sectional study Pediatr Res 44 1998 351-356
40. Manco-Johnson M.U. Antiphospholipid antibodies in children Semin Thromb Hemost 24 1998 591-598
41. Seelen M.A. Trouw L.A. Daha M.R. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus Curr Opin Nephrol Hypertens 12 2002 619-624
42. Oelzner P. Deliyska B. Funfstuck R. Hein G. Herrmann D. Stein G. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus-relationship with disease activity and renal involvement Clin Rheumatol 22 2003 271-278
43. Lach-Trifilieff E. Manfurt J. Schwarz S. Sadallah S. Schifferli J.A. Complement receptor I (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and human immunodeficiency virus infected patients J Immunol 162 1999 7549-7554
44. Tangye S.G. Liu Y.J. Aversa G. Phillips J.H. deVries J.E. Identification of functional human splenic memory B cells by expression of CH148 and CD27 J Exp Med 188 1998 1679-1689
45. Odendahl M. Jacobi A. Hansen A. Feist E. Hiepe F. Burmeister G.R. et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus J Immunol 165 2000 5970-5979
46. Arce E. Jackson D.G. Gill M.A. Bennett L.H. Banchereau J. Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus J Immunol 167 2001 2361-2369
47. Odendahl M. Keitzer R. Wahn U. Hiepe F. Radbruch A. Dorner T. et al. Perturbations of peripheral B lymphocyte homeostasis in children with systemic lupus erythematosus Ann Rheum Dis 62 2003 851-858
48. Schaller J. Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease Ann Intern Med 76 1972 747-750
49. Reveille J.D. Arnett F.C. Wilson R.W. Bias W.B. McLean R.H. Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus Immunogenetics 21 1985 299-311
50. Steinsson K. Arnason A. Erlendsson K. Fossdal R. Skaftadottir I. Jonsdottir S. et al. A study of the major histocompatibilty complex in a Caucasian family with multiple cases of systemic lupus erythematosus: association with the C4AQ0 phenotype J Rheumatol 22 1995 1862-1866
51. Pickering M.C. Botto M. Taylor P.R. Lachmann P.J. Walport M.J. Systemic lupus erythematosus, complement deficiency and Apoptosis Adv Immunol 76 2001 227-324
52. Hong G.H. Kim H.Y. Takeuchi F. Nakano K. Yamada H. Matsuta K. et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans J Rheumatol 21 1994 442-447
53. Moulds J.M. Warner N.B. Arnett F.C. Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity J Rheumatol 20 1993 443-447
54. Foeldvari I. Kimura Y. Jacobs J.C. Congenital complement deficiency in childhood lupus: 17% require little or no treatment Arthritis Rheum 33S 1990 S144
55. Fiedler A.H.L. Walport M.J. Batchelor J.R. Rynes R.I. Black C.M. Dodi I.A. et al. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: Importance of null alleles of C4A and C4B in determining disease susceptibility BMJ 286 1983 425-428
56. Ochs H.D. Rosenfeld S.I. Thomas E.D. Giblett E.R. Alper C.A. Dupont B. et al. Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex N Engl J Med 296 1977 470-475
57. Agnello V. DeBracco M.M.E. Kunkel H.G. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus J Immunol 108 1972 837-840
58. Gewurz A. Lint T.F. Robert J.L. Zeitz H. Gerwurz H. Homozygous C2 deficiency with fulminant lupus erythematosus Arthritis Rheum 21 1978 28-36
59. Davies K.A. Robson M.G. Peters A.M. Norsworthy P. Nash J.T. et al. Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus Arthritis Rheum 46 2002 1028-1038
60. Wu J. Edberg J.C. Redecha P.B. Bansal V. Guyre P.M. Coleman K. et al. A novel polymorphism of FcgammaRIIIa receptor (CD16) alters receptor function and predisposes to autoimmune disease J Clin Invest 100 1997 1059-1070
61. Salmon J.E. Millard S. Schachter L.A. Arnett F.C. Ginzler E.M. Gourley M.F. et al. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans J Clin Invest 97 1996 1348-1354
62. Zuniga R. Ng S. Peterson M.G. Reveille J.D. Baethge B.A. Alarcon G.S. et al. Low-binding alleles of Fc gamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients Arthritis Rheum 44 2001 361-367
63. Song Y.W. Han C.W. Kang S.W. Baek H.J. Lee E.B. Shin C.H. et al. Abnormal distribution of Fc gamma receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus Arthritis Rheum 41 1998 421-426
64. Duits A.J. Bootsma H. Derksen R.H. Spronk F.L. Kater L. Kallenberg C.G. et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients Arthritis Rheum 29 1995 1832-1836
65. Botto M. Theodoridis E. Thompson E.M. Beynon H.L. Briggs D. Isenberg D.A. et al. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease Clin Exp Immunol 104 1996 264-268
66. D'Alfonso S. Rampi M. Bocchio D. Colombo G. Scorza-Smeraldi R. Momigliano-Richardi P. Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10 Arthritis Rheum 43 2000 120-128
67. Dijstelbloen H.M. Bijl M. Fijnheer R. Scheepers R.H. Oost W.W. Jansen M.D. et al. Fc gamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes Arthritis Rheum 43 2000 2793-2800
68. Koene H.R. Kleijer M. Swaak A.J. Sullivan K.E. Bijl M. Petri M. et al. The Fc gamma RIIIA-158F allele is a risk factor for systemic lupus erythematosus Arthritis Rheum 41 1998 1813-1818
69. Manger K. Repp R. Spriewald B.M. Rascu A. Geiger A. Wassmuth R. et al. Fc gamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms Arthritis Rheum 41 1998 1181-1189
70. Salmon J.E. Ng S. Yoo D.H. Kim T.H. Kim S.Y. Song G.G. Altered distribution of Fcgamma receptor IIIA alleles in a cohort of Korean patients with lupus nephritis Arthritis Rheum 42 1999 818-819
71. Brunner H.I. Feldman B.M. Bombardier C. Silverman E.D. Sensitivity of the systemic lupus erythematosus disease activity index, British Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus Arthritis Rheum 42 1999 1354-1360
72. Brunner H.I. Silverman E.D. Bombardier C. Feldman B.M. European consensus lupus activity measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus Arthritis Rheum 49 2003 335-341
73. Esdaile J.M. Joseph L. Abrahamowicz M. Danoff D. Clarke A.E. Routine immunologic tests in systemic lupus erythematosus: Is there a need for more studies? J Rheumatol 23 1996 1891-1896
74. ter Borg E.J. Horst G. Hummel E.J. Limburg P.C. Kallenberg C.G. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbations in systemic lupus erythematosus: a long-term, prospective study Arthritis Rheum 33 1990 634-643
75. Roman M.J. Shanker B.A. Davis A. Lockshin M.D. Sammaritano L. Simantor R. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus N Engl J Med 349 2003 2399-2406
76. Klein-Gitelman M.S. Shore R. Peterson K. Pachman L.M. Bone mineral density (BMD) at diagnosis and after treatment (TX) of pediatric systemic lupus erythematosus Arthritis Rheum 39S 1996 S188
77. Traynor A.E. Barr W.G. Rosa K.M. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients Arthritis Rheum 46 2002 2917-2923
78. Wulffraat N.M. Sanders E.A. Kamphuis S.S. Rijkers G.I. Kuis W. Lilien M. et al. Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus Arthritis Rheum 44 2001 728-731
79. Richaud-Patin Y. Wijdenes J. Cardiel M. et al. Treatment of systemic lupus erythematosus with an anti-interleukin-10 monoclonal antibody Arthritis Rheum 41S 1998 S109
80. Dror Y. Blachar Y. Cohen P. Livni N. Rosenmann E. Ashkenazi A. Systemic lupus erythematosus associated with acute Epstein-Barr virus infection Am J Kidney Dis 32 1998 825-828
81. Moore T.L. Bandlamudi R. Alam S.M. Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population Semin Arthritis Rheum 28 1999 314-318
82. Trapani S. Ermini M. Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus Semin Arthritis Rheum 28 1999 319-325
83. Meyer O. Parvovirus B19 and autoimmune diseases Joint Bone Spine 70 2003 6-11
84. von Landenberg P. Lehmann H.W. Knoll A. Dorsch S. Modrow S. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection Arthritis Rheum 48 2003 1939-1947
85. James J.A. Kaufman J.M. Farris A.D. Taylor-Albert E. Lehman T.J. Harley J.B. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus J Clin Invest 100 1997 3019-3026
86. Harley J.B. James J.A. Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers Arthritis Rheum 42 1999 1782-1783
87. Stephan J.L. Jeannoel P. Chanoz J. Gentil-Perret A. Epstein-Barr virus-associated Kikuchi disease in two children Am J Pediatr Hematol Oncol 23 2001 240-243
88. Battafarano D.F. Battafarao N.J. Larsen L. Dyer P.D. Older S.A. Muehlbauer S. et al. Antigen-specific antibody responses in lupus patients following immunization Arthritis Rheum 41 1999 1828-1834
89. McDonald E. Jarrett M.P. Schiffman G. Grayzel A.I. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus J Rheumatol 11 1980 306-308
90. Jarrett M.P. Schiffman G. Barland P. Grayzel A.I. Impaired response to Pneumococcal vaccine in systemic lupus erythematosus Arthritis Rheum 23 1980 1287-1293
91. Klippel J.H. Karsh J. Stahl N.I. Decker J.L. Steinberg A.D. Schiffman G. A controlled study of Pneumococcal polysaccharide vaccine in systemic lupus erythematosus Arthritis Rheum 22 1979 1321-1325
92. Williams G.W. Steinberg A.D. Reinertsen J. Klassen L.W. Decker J.L. Dolin R. Influenza immunization in systemic lupus erythematosus Ann Intern Med 88 1978 729-734
93. Ristow S.C. Douglas R.G. Condemi J.J. Influenza vaccination of patients with systemic lupus erythematosus Ann Intern Med 88 1978 786-789